139 related articles for article (PubMed ID: 37004554)
21. Detection of high-risk human papillomavirus subtypes in cervical glandular neoplasia by in situ hybridization.
Sheng Z; Minato H; Sasagawa T; Nakada S; Kinoshita E; Kurose N; Nojima T; Makinoda S
Int J Clin Exp Pathol; 2013; 6(10):2168-77. PubMed ID: 24133595
[TBL] [Abstract][Full Text] [Related]
22. Anal intraepithelial neoplasia: correlation of grade with p16INK4a immunohistochemistry and HPV in situ hybridization.
Bernard JE; Butler MO; Sandweiss L; Weidner N
Appl Immunohistochem Mol Morphol; 2008 May; 16(3):215-20. PubMed ID: 18301250
[TBL] [Abstract][Full Text] [Related]
23. Superficial (early) endocervical adenocarcinoma in situ: a study of 12 cases and comparison to conventional AIS.
Witkiewicz A; Lee KR; Brodsky G; Cviko A; Brodsky J; Crum CP
Am J Surg Pathol; 2005 Dec; 29(12):1609-14. PubMed ID: 16327433
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus DNA in glandular dysplasia and microglandular hyperplasia: presumed precursors of adenocarcinoma of the uterine cervix.
Tase T; Okagaki T; Clark BA; Twiggs LB; Ostrow RS; Faras AJ
Obstet Gynecol; 1989 Jun; 73(6):1005-8. PubMed ID: 2542853
[TBL] [Abstract][Full Text] [Related]
25. Correlation of human papillomavirus 16 and 18 with cervical neoplasia in histological typing and clinical stage in Taiwan: an in-situ polymerase chain reaction approach.
Shyu JS; Chen CJ; Chiu CC; Huang SC; Harn HJ
J Surg Oncol; 2001 Oct; 78(2):101-9. PubMed ID: 11579387
[TBL] [Abstract][Full Text] [Related]
26. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
[TBL] [Abstract][Full Text] [Related]
27. In-situ hybridization using biotinylated DNA probes to human papillomavirus in adenocarcinoma-in-situ and endocervical glandular dysplasia of the uterine cervix.
Leary J; Jaworski R; Houghton R
Pathology; 1991 Apr; 23(2):85-9. PubMed ID: 1660591
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus-specific genotypes in cervical lesions of women referred for smears with atypical glandular cells or adenocarcinoma in situ.
Rabelo-Santos SH; Derchain SF; Villa LL; Costa MC; Sarian LO; do Amaral Westin MC; Kornegay J; Zeferino LC
Int J Gynecol Pathol; 2009 May; 28(3):272-8. PubMed ID: 19620946
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus associated with adenocarcinoma and adenosquamous carcinoma of the cervix: analysis by in situ hybridization.
Gordon AN; Bornstein J; Kaufman RH; Estrada RG; Adams E; Adler-Storthz K
Gynecol Oncol; 1989 Dec; 35(3):345-8. PubMed ID: 2557270
[TBL] [Abstract][Full Text] [Related]
30. Clear cell adenosquamous carcinoma of the cervix. An aggressive tumor associated with human papillomavirus-18.
Fujiwara H; Mitchell MF; Arseneau J; Hale RJ; Wright TC
Cancer; 1995 Nov; 76(9):1591-600. PubMed ID: 8635063
[TBL] [Abstract][Full Text] [Related]
31. Cytological aspects of uterine cervical adenocarcinoma, adenosquamous carcinoma and combined adenocarcinoma-squamous carcinoma: appraisal of diagnostic criteria for in situ versus invasive lesions.
Hayes MM; Matisic JP; Chen CJ; Mohamed A; Anderson GH; LeRiche JC; Amy R
Cytopathology; 1997 Dec; 8(6):397-408. PubMed ID: 9439892
[TBL] [Abstract][Full Text] [Related]
32. The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia.
Sehnal B; Dusek L; Cibula D; Zima T; Halaska M; Driak D; Slama J
J Clin Virol; 2014 Jan; 59(1):18-23. PubMed ID: 24315797
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus messenger RNA expression in adenocarcinoma in situ of the uterine cervix.
Farnsworth A; Laverty C; Stoler MH
Int J Gynecol Pathol; 1989; 8(4):321-30. PubMed ID: 2553629
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus type 18 DNA sequences in adenocarcinoma and adenosquamous carcinoma of the uterine cervix.
Teshima H; Beaudenon S; Koi S; Katase K; Hasumi K; Masubuchi K; Orth G
Arch Gynecol Obstet; 1997; 259(4):169-77. PubMed ID: 9271836
[TBL] [Abstract][Full Text] [Related]
35. HPV-driven anal neoplasia: review and recent developments.
Assarzadegan N; Brooks E; Voltaggio L
Pathology; 2022 Mar; 54(2):184-194. PubMed ID: 34645567
[TBL] [Abstract][Full Text] [Related]
36. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix.
Jaworski RC
Semin Diagn Pathol; 1990 Aug; 7(3):190-204. PubMed ID: 2171126
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus detection in adenocarcinoma and adenosquamous carcinoma of the uterine cervix in Taiwan.
Tseng HH; Wang JS; Kan YY
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):47-53. PubMed ID: 8820036
[TBL] [Abstract][Full Text] [Related]
38. Application of p16 Immunohistochemistry and RNA In Situ Hybridization in the Classification of Adenoid Basal Tumors of the Cervix.
Goyal A; Wang Z; Przybycin CG; Yang B
Int J Gynecol Pathol; 2016 Jan; 35(1):82-91. PubMed ID: 26352551
[TBL] [Abstract][Full Text] [Related]
39. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
40. Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia.
Riethdorf L; Riethdorf S; Lee KR; Cviko A; Löning T; Crum CP
Hum Pathol; 2002 Sep; 33(9):899-904. PubMed ID: 12378514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
